Format

Send to

Choose Destination
Lung Cancer. 2014 Aug;85(2):101-9. doi: 10.1016/j.lungcan.2014.05.005. Epub 2014 May 14.

Immunotherapy in the treatment of non-small cell lung cancer.

Author information

1
Department of Haematology-Oncology, National University Cancer Institute, National University Health System, Singapore.
2
Cancer Science Institute of Singapore, National University of Singapore, Singapore; Department of Pathology, National University Health System, Singapore.
3
Division of Medical Oncology, Yonsei Cancer Center, Seoul, South Korea.
4
Department of Oncology, The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins, Baltimore, MD, United States.
5
Department of Haematology-Oncology, National University Cancer Institute, National University Health System, Singapore; Cancer Science Institute of Singapore, National University of Singapore, Singapore; Department of Surgery, University of Western Australia, Australia. Electronic address: ross_soo@nuhs.edu.sg.

Abstract

Advances in the understanding of the role of the immune system in tumor immunosurveillance have resulted in the recognition that tumors can evade immune destruction via the dysregulation of co-inhibitory or checkpoint signals. This has led to the development of a generation immunotherapeutic agents targeting the immune checkpoint pathway. Recent early phase studies of immune checkpoint modulators, such as CTLA-4, PD-1 and PD-L1 inhibitors in NSCLC have reported promising results with prolonged clinical responses and tolerable toxicity. This article provides an overview of co-stimulatory and inhibitory molecules that regulate the immune response to tumors, recent therapies that have been developed to exploit these interactions and the role of predictive biomarkers in treatment selection.

KEYWORDS:

CTLA-4; Immunotherapy; Ipilimumab; Nivolumab; Non-small cell lung cancer; PD-L1

PMID:
24880938
PMCID:
PMC4332778
DOI:
10.1016/j.lungcan.2014.05.005
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Elsevier Science Icon for PubMed Central
Loading ...
Support Center